Extract preparation – virtual exception
The Centers for Medicare and Medicaid Services (CMS) previously established this “immediate availability” requirement to mean in-person – not virtual – availab…
Extract preparation – physician supervision
Medicare rules require that a physician (or other supervising practitioner) be on-site at the location where allergy extract vials are prepared.
Tezspire administration remains an in-office procedure
Medicare Administrative Contractors publicly announced removal of Tezspire from their Self-Administration Drug (SAD) exclusion lists.
Drug prices lowered for Medicare beneficiaries and ACA subsidies extended
After more than a year of trying to pass the Build Back Better Act, Congress passed a slimmer version, the Inflation Reduction Act.
Telehealth – Proposed bill extends coverage through the end of 2024
The COVID-19 Public Health Emergency could end before Congress determines how to permanently expand these coverage policies.
Billing – how do your claims compare to other allergists?
Only allergists with billing patterns significantly higher than either their peer group or national averages will receive a CBR.
Tezspire – advocacy thwarts move to SAD list
Due to the efforts of the Advocacy Council and other medical organizations, Tezspire administration remains in the physician office setting.
Telehealth and HIPAA Compliance
HHS recently issued guidance clarifying how providers may use remote communication technologies for audio-only telehealth services after the conclusion of the …
Peanut Allergy – we testify on behalf of our patients
This event was organized by the National Peanut Board.
2023 cuts in reimbursement – we advocate against them
These looming cuts are the result of several policies that have a combined effect of reducing Medicare payments by as much as 9%.
95004 – Medicare billing and coding guidance
Billing requirements may vary by payer, so allergists should consult with the payer to determine their billing and coding requirements.
Keeping up with compounding
At the FDA Annual Compounding Listening Session, a number of compounding topics were discussed, such as marketing of IV rehydration clinics.
The AMA celebrates 175 years
The AMA celebrates 175 years of service to the medical community this year, and the College has had a long-standing partnership with the organization.
Congress builds support for prior authorizations reforms
Bipartisan support in Congress is building for one of ACAAI’s key legislative advocacy priorities. The Improving Seniors’ Timely Access to Care Act, which woul…
Coding for telehealth
Many payers, including Medicare, provided coverage for telehealth services prior to the COVID-19 public health emergency (PHE). Over the past two years, there …
Records audits are on the rise
Members have advised the Advocacy Council of an issue that seems to be spreading nationwide – audits by insurers of claims submitted by allergy practices for r…
Medical debt collection landscape to change
The Biden Administration recently announced an initiative to evaluate how providers’ billing practices impact access and affordability of care and the accrual …
Join Us! Thursday, May 19: New England Regional Town Hall Meeting
New England Regional Town Hall MeetingThursday, May 196:30 – 7:30 pm ETJoin us for ACAAI’s House of Delegates New England Regional Town Hall Meeting, Thursday,…
Leadership advocates for allergists and our specialty
After a three-year hiatus, your Advocacy Council Strike Force has resumed in-person advocacy. Last week, the following College leaders visited Washington, DC, …
Administering drugs/biologics in physicians’ offices
Claims for drugs/biologics should be billed using the HCPCS/CPT code that most accurately describes the drug. Information in this article concerns drug adminis…
